Related Experiment Video
Updated: Nov 3, 2025

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Zerumbone Inhibits Helicobacter pylori Urease Activity
Hyun Jun Woo1, Ji Yeong Yang2, Pyeongjae Lee3
1Department of Clinical Laboratory Science, Semyung University, Jecheon 27136, Korea.
Zerumbone, a natural compound, inhibits Helicobacter pylori (H. pylori) urease by forming complexes with urease molecules. This discovery offers a potential new therapeutic strategy for H. pylori infections.
Area of Science:
- Microbiology
- Biochemistry
- Natural Product Chemistry
Background:
- Helicobacter pylori (H. pylori) utilizes urease for gastric colonization.
- Existing urease inhibitors face challenges with instability and toxicity in clinical applications.
Purpose of the Study:
- To investigate zerumbone, a compound from Zingiber zerumbet Smith, as a potential inhibitor of H. pylori urease.
- To explore the mechanism of zerumbone's inhibition, specifically its ability to form urease complexes.
Main Methods:
- Studied the interaction between zerumbone and H. pylori urease A and B subunits.
- Assessed the effect of zerumbone on urease activity through complex formation (dimerization, trimerization, tetramerization).
- Analyzed gene transcription and protein expression of urease A and B in the presence of zerumbone.
Main Results:
- Zerumbone successfully formed dimers, trimers, and tetramers with both H. pylori urease A and urease B molecules.
- The formation of these zerumbone-urease complexes led to significant inhibition of H. pylori urease activity.
- Zerumbone did not influence the gene transcription or protein expression levels of urease A and B.
Conclusions:
- Zerumbone effectively inhibits H. pylori urease activity via complex formation, without affecting enzyme production.
- Zerumbone demonstrates potential as a safe and effective therapeutic agent for H. pylori infections.
More Related Videos
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...

